Author:
Ding Yiqian,Wang Xin,Zhang Fan,Yan Hao,Liu Yaoyao,Zhang Lan
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.
2. Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584–90.
3. Jalili S, Ghasemi Shayan R. A comprehensive evaluation of Health-Related Life Quality Assessment through Head and Neck, prostate, breast, lung, and skin Cancer in adults. Front Public Health. 2022;10:789456.
4. Bingqun W, Shenhai W, Jintao T, Xiaoping S, Pengcheng H. Comparison of survival time of non-small cell lung cancer patients with different metastatic sites. Chin J Lung Cancer. 2019;22(02):105–10.
5. Chengdi W, Bojiang C, Lujia S, Jun S, Dina L, Weiming L. Clinical epidemiological and pathological characteristics of 23,228 patients with lung cancer. West China Med J. 2020;35(07):813–20.